Lymphoma immunotherapy: vaccines, adoptive cell transfer and immunotransplant.

Immunotherapy
Joshua Brody, Ronald Levy

Abstract

Therapy for non-Hodgkin lymphoma has benefited greatly from basic science and clinical research such that chemotherapy and monoclonal antibody therapy have changed some lymphoma subtypes from uniformly lethal to curable, but the majority of lymphoma patients remain incurable. Novel therapies with less toxicity and more specific targeting of tumor cells are needed and immunotherapy is among the most promising of these. Recently completed randomized trials of idiotype vaccines and earlier-phase trials of other vaccine types have shown the ability to induce antitumor T cells and some clinical responses. More recently, trials of adoptive transfer of antitumor T cells have demonstrated techniques to increase the persistence and antitumor effect of these cells. Herein, we discuss lymphoma immunotherapy clinical trial results and what lessons can be taken to improve their effect, including the combination of vaccination and adoptive transfer in an approach we have dubbed 'immunotransplant'.

References

Mar 4, 1982·The New England Journal of Medicine·R A MillerR Levy
Mar 1, 1995·Bone·C H Turner, M R Forwood
Jan 1, 1997·Kidney & Blood Pressure Research·M E Safar, G M London
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·A A McCormickR Levy
Jan 13, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I F KhouriR Champlin
Sep 7, 2000·The Journal of Experimental Medicine·M J SmythJ A Trapani
Oct 24, 2001·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·T A DavisR Levy
Jul 5, 2002·The New England Journal of Medicine·Atsuko HataAnn M Arvin
May 27, 2003·Nature Reviews. Immunology·Christopher V Nicchitta
Sep 6, 2003·Methods : a Companion to Methods in Enzymology·A ChahroudiM B Feinberg
Apr 20, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jinjuan WangMichael C Jensen
May 11, 2004·Cancer Immunology, Immunotherapy : CII·Dirk NagorsenFrédéric Lévy
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allen M ChenThomas A Buchholz
Nov 9, 2004·Advances in Cancer Research·Li Yang, David P Carbone
Dec 22, 2004·The Journal of Experimental Medicine·Catherine M BollardHelen E Heslop
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sattva S NeelapuLarry W Kwak
Mar 4, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Thomas LeemhuisRobert S Negrin
Mar 4, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Joseph H AntinDeborah C Molrine
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
May 27, 2005·Cancer Immunology, Immunotherapy : CII·David E SpanerAndrea Deabreu
Jun 14, 2005·Current Opinion in Immunology·Maria A SuniHolden T Maecker
Aug 12, 2005·Current Opinion in Oncology·Sara A Hurvitz, John M Timmerman
Sep 10, 2005·Blood·Carol Ann HuffRichard J Jones
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ettore BiagiMalcolm Brenner
Feb 18, 2006·The Journal of Investigative Dermatology·Rachael A ClarkThomas S Kupper

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
xenograft

Clinical Trials Mentioned

NCT00099593
NCT00608257
NCT00608478
NCT00182650

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.